- Home
- Publications
- Publication Search
- Publication Details
Title
One hundred years of insulin therapy
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-08-17
DOI
10.1038/s41574-021-00542-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glycaemic efficacy and safety of mealtime faster‐acting insulin aspart administered by injection as compared to insulin aspart in people with diabetes mellitus: A meta‐analysis of randomized controlled trials
- (2021) Rimesh Pal et al. DIABETIC MEDICINE
- The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
- (2020) David R. Owens et al. DIABETES OBESITY & METABOLISM
- Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial
- (2020) Athena Philis-Tsimikas et al. DIABETOLOGIA
- Ultra Rapid Lispro Lowers Postprandial Glucose and More Closely Matches Normal Physiological Glucose Response Compared to Other Rapid Insulin Analogs: A Phase 1 Randomized, Crossover Study
- (2020) Tim Heise et al. DIABETES OBESITY & METABOLISM
- Lower risk of severe hypoglycaemia with insulin glargine 300 U/ mL versus glargine 100 U/ mL in participants with type 1 diabetes: A meta‐analysis of 6‐month phase 3 clinical trials
- (2020) Thomas Danne et al. DIABETES OBESITY & METABOLISM
- Ultra rapid lispro improves postprandial glucose control compared with lispro in patients with type 1 diabetes: Results from the 26‐week PRONTO‐T1D study
- (2020) Leslie Klaff et al. DIABETES OBESITY & METABOLISM
- Compatibility and Safety of Ultra Rapid Lispro with Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: PRONTO-Pump Study
- (2020) Bruce Bode et al. Diabetes Technology & Therapeutics
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review: Glucose-sensitive insulin
- (2020) Thomas Hoeg-Jensen Molecular Metabolism
- Oral insulin: time to rewrite the textbooks
- (2019) Chantal Mathieu Lancet Diabetes & Endocrinology
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
- (2019) Jonas Kildegaard et al. PHARMACEUTICAL RESEARCH
- The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s
- (2019) Michael Fralick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anionic nanoparticles enable the oral delivery of proteins by enhancing intestinal permeability
- (2019) Nicholas G. Lamson et al. Nature Biomedical Engineering
- Insulin Access and Affordability Working Group: Conclusions and Recommendations
- (2018) William T. Cefalu et al. DIABETES CARE
- Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial
- (2018) Chantal Mathieu et al. DIABETES OBESITY & METABOLISM
- A history of blood glucose meters and their role in self-monitoring of diabetes mellitus
- (2018) S. F. Clarke et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- More Similarities Than Differences Testing Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Insulin-Naive Type 2 Diabetes: The Randomized Head-to-Head BRIGHT Trial
- (2018) Julio Rosenstock et al. DIABETES CARE
- Mechanisms of Insulin Action and Insulin Resistance
- (2018) Max C. Petersen et al. PHYSIOLOGICAL REVIEWS
- Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?
- (2018) Harriet Warnes et al. Diabetes Therapy
- A randomized, multicentre trial evaluating the efficacy and safety of fast‐acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)
- (2018) David C. Klonoff et al. DIABETES OBESITY & METABOLISM
- Expert Opinion: Patient Selection for Premixed Insulin Formulations in Diabetes Care
- (2018) Sanjay Kalra et al. Diabetes Therapy
- Insulin analogues in type 1 diabetes mellitus: getting better all the time
- (2017) Chantal Mathieu et al. Nature Reviews Endocrinology
- Strategies to improve the affordability of insulin in the USA
- (2017) Jing Luo et al. Lancet Diabetes & Endocrinology
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial
- (2016) Julio Rosenstock et al. DIABETES CARE
- Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial
- (2016) Vanita R. Aroda et al. DIABETES CARE
- Randomized, double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 3
- (2016) R. M. Bergenstal et al. DIABETES OBESITY & METABOLISM
- A randomized clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 1 diabetes: IMAGINE 1
- (2016) S. Garg et al. DIABETES OBESITY & METABOLISM
- Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes
- (2016) Tim Heise et al. DIABETES OBESITY & METABOLISM
- Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes
- (2016) Richard M. Bergenstal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- How Can a Good Idea Fail? Basal Insulin Peglispro [LY2605541] for the Treatment of Type 2 Diabetes
- (2016) Araceli Muñoz-Garach et al. Diabetes Therapy
- Performance of Blood Glucose Meters in the Low-Glucose Range: Current Evaluations Indicate That It Is Not Sufficient From a Clinical Point of View
- (2015) Lutz Heinemann et al. DIABETES CARE
- Inhaled Technosphere Insulin Compared With Injected Prandial Insulin in Type 1 Diabetes: A Randomized 24-Week Trial
- (2015) Bruce W. Bode et al. DIABETES CARE
- Comparison of Basal-Bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes
- (2015) Virginia Bellido et al. DIABETES CARE
- Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine
- (2015) Tim Heise et al. Expert Opinion on Drug Metabolism & Toxicology
- Trends in Medicaid Reimbursements for Insulin From 1991 Through 2014
- (2015) Jing Luo et al. JAMA Internal Medicine
- Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial
- (2014) Gregory R. Fulcher et al. DIABETES CARE
- Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)
- (2014) John B. Buse et al. DIABETES CARE
- Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes
- (2014) Stephen C L Gough et al. Lancet Diabetes & Endocrinology
- A Comparison of the Steady-State Pharmacokinetic and Pharmacodynamic Profiles of 100 and 200 U/mL Formulations of Ultra-Long-Acting Insulin Degludec
- (2013) Stefan Korsatko et al. CLINICAL DRUG INVESTIGATION
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes
- (2013) G. Koehler et al. DIABETES OBESITY & METABOLISM
- PEGylated insulin Lispro, (LY2605541)-a new basal insulin analogue
- (2013) T. M. Caparrotta et al. DIABETES OBESITY & METABOLISM
- A comparison of insulin detemir and neutral protamine Hagedorn (isophane) insulin in the treatment of diabetes: a systematic review
- (2013) B. M. Frier et al. DIABETES OBESITY & METABOLISM
- Basal insulin analogues in the management of diabetes mellitus: what progress have we made?
- (2013) David R. Owens et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Insulin Stacking Versus Therapeutic Accumulation: Understanding the Differences
- (2013) Tim Heise et al. Endocrine Practice
- Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes
- (2013) Trang T. Ly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The current state of pancreas transplantation
- (2013) Rainer W. G. Gruessner et al. Nature Reviews Endocrinology
- Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: A narrative review (预混胰岛素类似物在2型糖尿病治疗中的作用:叙述性综述)
- (2013) Svetlana Elizarova et al. Journal of Diabetes
- Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
- (2012) R. E. Ratner et al. DIABETES OBESITY & METABOLISM
- Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes
- (2012) T. Heise et al. DIABETES OBESITY & METABOLISM
- Insulin and its analogues and their affinities for the IGF1 receptor
- (2012) Aimee J Varewijck et al. ENDOCRINE-RELATED CANCER
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
- (2011) A. de la Pena et al. DIABETES CARE
- Hypoglycemia and Cardiovascular Risks
- (2011) B. M. Frier et al. DIABETES CARE
- An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: The A1chieve study
- (2011) Philip Home et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Insulin Preparations with Prolonged Effect
- (2011) David R. Owens Diabetes Technology & Therapeutics
- Elizabeth Evans Hughes—surviving starvation therapy for diabetes
- (2011) Caroline Cox LANCET
- Why were "starvation diets" promoted for diabetes in the pre-insulin period?
- (2011) Allan Mazur Nutrition Journal
- Dose-Dependent Delay of the Hypoglycemic Effect of Short-Acting Insulin Analogs in Obese Subjects With Type 2 Diabetes: A pharmacokinetic and pharmacodynamic study
- (2010) M. Gagnon-Auger et al. DIABETES CARE
- Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients
- (2009) I-Te Lee et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis
- (2008) M. Monami et al. DIABETES OBESITY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now